Abstract
AIMP2-DX2 (hereafter DX2) is an oncogenic variant of aminoacyl-tRNA synthetase-interacting multifunctional protein 2 (AIMP2) that mediates tumorigenic interactions with various factors involved in cancer. Reducing the levels of DX2 can effectively inhibit tumorigenesis. We previously reported that DX2 can be degraded through Siah1-mediated ubiquitination. In this study, we identified a compound, SDL01, which enhanced the interaction between DX2 and Siah1, thereby facilitating the ubiquitin-dependent degradation of DX2. SDL01 was found to bind to the pocket surrounding the N-terminal flexible region and GST domain of DX2, causing a conformational change that stabilized its interaction with Siah1. Our findings demonstrate that protein-protein interactions (PPIs) can be modulated through chemically induced conformational changes.
| Original language | English |
|---|---|
| Pages (from-to) | 1958-1968.e8 |
| Journal | Cell Chemical Biology |
| Volume | 31 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - 2024 Nov 21 |
Bibliographical note
Publisher Copyright:© 2024 Elsevier Ltd
Keywords
- AIMP2-DX2
- Siah1
- allosteric modulation
- and molecular docking
- small molecule
- ubiquitination
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine
- Molecular Biology
- Pharmacology
- Drug Discovery
- Clinical Biochemistry